50
Participants
Start Date
December 8, 2015
Primary Completion Date
January 5, 2018
Study Completion Date
June 27, 2018
Ixazomib Citrate
Given PO
Laboratory Biomarker Analysis
Correlative studies
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Moffitt Cancer Center, Tampa
Cleveland Clinic Foundation, Cleveland
Washington University School of Medicine, St Louis
University of Nebraska Medical Center, Omaha
Fred Hutch/University of Washington Cancer Consortium, Seattle
National Cancer Institute (NCI)
NIH
Fred Hutchinson Cancer Center
OTHER